SCHEMBL30132097

SCHEMBL30132097

Oc1ncnc2c1cnn2-c1ccccc1CCl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 4/20 0.41
SLC2A2 P11168 4/20 0.41
SLC2A3 P11169 4/20 0.41
KDM4E B2RXH2 7/20 0.40
ALDH1A1 P00352 5/20 0.40
TSHR P16473 3/20 0.40
HSD17B10 Q99714 3/20 0.40
MEN1 O00255 1/20 0.40
EGFR P00533 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C19 P33261 1/20 0.40
PI4KA P42356 1/20 0.40
KMT2A Q03164 1/20 0.40
PI4K2B Q8TCG2 1/20 0.40
PI4K2A Q9BTU6 1/20 0.40
PI4KB Q9UBF8 1/20 0.40
MAPT P10636 6/20 0.39
POLB P06746 1/20 0.38
LMNA P02545 3/20 0.37
GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL878705 0.82 GCK (0.47) SLC2A1SLC2A2SLC2A3KDM4EALDH1A1
SCHEMBL849766 0.79 MAPT (0.46) SLC2A1SLC2A2SLC2A3KDM4EALDH1A1
SCHEMBL12000897 0.79 SLC2A1 (0.53) SLC2A1SLC2A2SLC2A3KDM4EALDH1A1
SCHEMBL838812 0.77 P2RX7 (0.44) SLC2A1SLC2A2SLC2A3KDM4EALDH1A1
SCHEMBL25343546 0.76 MAPT (0.52) SLC2A1SLC2A2SLC2A3KDM4EALDH1A1
SCHEMBL838206 0.76 SLC2A1 (0.56) SLC2A1SLC2A2SLC2A3KDM4EALDH1A1
SCHEMBL838726 0.76 GCK (0.44) SLC2A1SLC2A2SLC2A3KDM4EALDH1A1
SCHEMBL6205196 0.76 SLC2A1 (0.65) SLC2A1SLC2A2SLC2A3KDM4ECYP1A2
SCHEMBL31337054 0.75 ALDH1A1 (0.67) SLC2A1SLC2A2SLC2A3KDM4EALDH1A1
SCHEMBL6282033 0.75 ALDH1A1 (0.67) SLC2A1SLC2A2SLC2A3KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4100015-A1 COMBINATION THERAPY FOR TREATING MPS1 Gain Therapeutics SA (CH) 2022-12-14 EP disclosed